Fig. 4From: Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiencyImpact of ASMD on caregivers’ wellbeing which were reported to have improved since olipudase alfa treatment (n = 10). Again, the sum of percentages is higher than 100% as survey participants were able to identify multiple aspects of wellbeing which improvedBack to article page